CFO4Life’s Medtronic MDT Stock Holding History

CFO4Life’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$265K	Buy	+3,415	New	+$277K	0.06%	144

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CFO4Life's MDT Position: Q4 2022 in Review

CFO4Life opened a new position in Medtronic (MDT) in Q4 2022: 3,415 shares worth $265K. The stake represents 0.06% of the portfolio and ranks #144 among its holdings.

1,963 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

CFO4Life held 3,415 shares of Medtronic worth $265K as of Q4 2022.
Medtronic was a new CFO4Life position in Q4 2022.
Medtronic made up 0.06% of CFO4Life's portfolio in Q4 2022, its #144 holding.
1,963 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on CFO4Life's 13F filing for Q4 2022, filed 11 Jan 2023.